JonesTrading Downgrades Silverback Therapeutics to Hold

JonesTrading analyst Soumit Roy downgrades Silverback Therapeutics (NASDAQ:SBTX) from Buy to Hold.

byBenzinga Newsdesk

April 1, 2022

1 minute read

JonesTrading analyst Soumit Roy downgrades Silverback Therapeutics (NASDAQ:SBTX) from Buy to Hold.

Biogen Announces Topline Results from Phase 2 CONVEY Study in Small Fiber Neuropathy; Co. Reports ‘The CONVEY study 200 mg twice daily arm met its primary endpoint while the 350 mg twice daily arm did not meet the primary endpoint’

By Benzinga Newsdesk

Today, 10:18 PM

Biogen Inc. (NASDAQ:BIIB) today announced positive topline results from its Phase 2 CONVEY study of vixotrigine (BIIB074), a non-opioid investigational oral pain drug being evaluated for the treatment

BIIB

Media
News

LeVar Burton, Spurned As Potential ‘Jeopardy!’ Host, To Helm New ‘Trivial Pursuit’ Game Show

By Phil Hall

Today, 10:18 PM

Although LeVar Burton’s efforts to gain the host’s job on the long-running game show “Jeopardy!” came to naught, the actor has been signed to host a game show version of the popular board game “Trivial Pursuit,” which is now in development at Entertainment One (eOne), a subsidiary of Hasbro Inc.

HAS

News

‘Spider-Man: No Way Home’ Tops Box Office For Fourth Straight Week

By Phil Hall

Today, 10:18 PM

“Spider-Man: No Way Home” smacked aside both the fears of the omicron variant and the Hollywood competition to continue its dominance at the U.S. box office.

CMCSA